Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 4
1976 36
1977 26
1978 69
1979 131
1980 87
1981 88
1982 112
1983 124
1984 85
1985 89
1986 78
1987 102
1988 106
1989 104
1990 91
1991 87
1992 62
1993 65
1994 44
1995 35
1996 25
1997 20
1998 28
1999 31
2000 35
2001 26
2002 26
2003 22
2004 31
2005 26
2006 36
2007 31
2008 48
2009 44
2010 42
2011 52
2012 53
2013 46
2014 54
2015 60
2016 57
2017 58
2018 50
2019 60
2020 67
2021 56
2022 66
2023 70
2024 30

Text availability

Article attribute

Article type

Publication date

Search Results

2,750 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean transudate (18,249 results)?
Labetalol: a review of its pharmacology, pharmacokinetics, clinical uses and adverse effects.
MacCarthy EP, Bloomfield SS. MacCarthy EP, et al. Pharmacotherapy. 1983 Jul-Aug;3(4):193-219. doi: 10.1002/j.1875-9114.1983.tb03252.x. Pharmacotherapy. 1983. PMID: 6310529 Review.
Labetalol is a combined alpha- and beta-adrenoceptor blocking agent for oral and intravenous use in the treatment of hypertension. ...Labetalol administered alone or with a diuretic is often effective when other antihypertensive regimens have failed. ...
Labetalol is a combined alpha- and beta-adrenoceptor blocking agent for oral and intravenous use in the treatment of hypertension. ..
Labetalol.
Carter BL. Carter BL. Drug Intell Clin Pharm. 1983 Oct;17(10):704-12. Drug Intell Clin Pharm. 1983. PMID: 6354658 Review.
Labetalol is a competitive antagonist of alpha 1-, beta 1-, and beta 2-adrenergic receptors. ...Reductions in heart rate are less pronounced with labetalol as compared with propranolol. Labetalol produces rapid reductions in blood pressure when administered i
Labetalol is a competitive antagonist of alpha 1-, beta 1-, and beta 2-adrenergic receptors. ...Reductions in heart rate are less pro
Fatal intoxication with labetalol (Trandate).
Grassin Delyle S, Duverneuil-Mayer C, Abe E, Mathieu B, Lorin De La Grandmaison G, Charlier P, Alvarez JC. Grassin Delyle S, et al. Forensic Sci Int. 2008 Jul 4;178(2-3):e19-21. doi: 10.1016/j.forsciint.2008.03.003. Epub 2008 Apr 10. Forensic Sci Int. 2008. PMID: 18406090
Ethanol has been found (1.24 g/L in blood, 2.63 g/L in urine and 1.33 g/kg in gastric content), as well as therapeutic concentrations of meprobamate (14.1mg/L) and low concentrations of nordazepam (0.12 mg/L) in blood. On the other hand, particularly high levels of labetalol
Ethanol has been found (1.24 g/L in blood, 2.63 g/L in urine and 1.33 g/kg in gastric content), as well as therapeutic concentrations of mep …
Labetalol in hypertension.
[No authors listed] [No authors listed] Lancet. 1977 Apr 23;1(8017):890-1. Lancet. 1977. PMID: 67294 No abstract available.
Labetalol ('trandate') in hypertension: a multicentre study in general practice.
Gomez G, Phillips LA. Gomez G, et al. Curr Med Res Opin. 1980;6(10):677-84. doi: 10.1185/03007998009110080. Curr Med Res Opin. 1980. PMID: 7428406
A study was carried out in 1286 hypertensive patients seen in general practice to evaluate the effectiveness of labetalol given for periods of up to 24 months. Initial dosage was 300 mg per day. The results showed that blood pressure was readily controlled and maintained b …
A study was carried out in 1286 hypertensive patients seen in general practice to evaluate the effectiveness of labetalol given for p …
Oral nifedipine may be a preferential option for treating acute severe hypertension during pregnancy: a meta-analysis.
Ou M, Zhang F, Cui S, Zhao S, Yu Y. Ou M, et al. Hypertens Pregnancy. 2023 Dec;42(1):2209637. doi: 10.1080/10641955.2023.2209637. Hypertens Pregnancy. 2023. PMID: 37434338 Free article. Review.
AIM: To compare oral nifedipine and intravenous labetalol in the treatment of acute severe hypertension in pregnancy (SHP). ...CONCLUSION: Oral nifedipine was associated with less RTATBP and NoD and otherwise did not differ from intravenous labetalol....
AIM: To compare oral nifedipine and intravenous labetalol in the treatment of acute severe hypertension in pregnancy (SHP). ...CONCLU …
Labetalol hepatotoxicity.
[No authors listed] [No authors listed] Ann Intern Med. 1991 Feb 15;114(4):341. doi: 10.7326/0003-4819-114-4-341. Ann Intern Med. 1991. PMID: 2018583 No abstract available.
A controlled trial of labetalol (Trandate), propranolol and placebo in the management of mild to moderate hypertension.
Pugsley DJ, Nassim M, Armstrong BK, Beilin L. Pugsley DJ, et al. Br J Clin Pharmacol. 1979 Jan;7(1):63-8. doi: 10.1111/j.1365-2125.1979.tb00898.x. Br J Clin Pharmacol. 1979. PMID: 367410 Free PMC article. Clinical Trial.
Labetalol and propranolol lowered blood pressure satisfactorily in the supine position, but labetalol reduced blood pressure more in the erect posture and following exercise and induced less bradycardia. Thus alpha- as well as beta-adrenoceptor blocking actions appe
Labetalol and propranolol lowered blood pressure satisfactorily in the supine position, but labetalol reduced blood pressure m
Clinical pharmacology of labetalol in pregnancy.
Riley AJ. Riley AJ. J Cardiovasc Pharmacol. 1981;3 Suppl 1:S53-9. doi: 10.1097/00005344-198100031-00006. J Cardiovasc Pharmacol. 1981. PMID: 6169960 Review. No abstract available.
Clinical pharmacology of labetalol.
Richards DA, Prichard BN. Richards DA, et al. Br J Clin Pharmacol. 1979;8(Suppl 2):89S-93S. Br J Clin Pharmacol. 1979. PMID: 43165 Free PMC article. Review.
1 The clinical pharmacology of labetalol has been evaluated using pharmacological and physiological test methods. 2 Labetalol displaces the log dose-response curves to the right of isoprenaline-induced increases in heart rate, cardiac output and decreases in diastol …
1 The clinical pharmacology of labetalol has been evaluated using pharmacological and physiological test methods. 2 Labetalol
2,750 results